Scinai Immunotherapeutics Ltd. (SCNI) earnings
Quarterly results of Scinai Immunotherapeutics Ltd. as filed with the SEC: revenue, net income and earnings per share for each of the last 2 quarters, the latest results release and when the next one is expected.
Latest quarter: Q1 FY2023
In Q1 FY2023 (ended March 31, 2023) Scinai Immunotherapeutics Ltd. reported revenue of - and a net loss of $3.5M.
Diluted earnings per share were -$0.00.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q1 FY2023 | - | - | -$3.5M | -$0.00 |
| Q1 FY2022 | - | - | -$2.5M | -$0.00 |
Get an email when SCNI reports
Follow SCNI and we email you its next results the day they are filed, with the numbers explained.